Gleason grades of these tumours (Table 2) demonstrate that in 21% of the normal ERG/ETV1 and PTEN loss tumours, Gleason grade was <7 supporting a reclassification of this low Gleason grade patient subgroup. This evidence concerns the gene ERG and neoplasm.